# Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression

> **NCT02491242** · — · COMPLETED · sponsor: **Asociacion para el Estudio de las Enfermedades Infecciosas** · enrollment: 155 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **OTHER:** Dolutegravir in a dual therapy regimen

## Key facts

- **NCT ID:** NCT02491242
- **Lead sponsor:** Asociacion para el Estudio de las Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-03
- **Final completion:** 2018-06
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491242, "Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02491242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*